Examples of using Repeat dosing in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
The pharmacokinetics is not altered with repeat dosing.
Repeat dosing did not lead to further reduction of bone turnover markers.
Onset of induction is likely to occur after 3 days of repeat dosing with dabrafenib.
Repeat dosing: This 5-day treatment course can be repeated every 30 days.
severity of hypersensitivity with repeat dosing of sugammadex.
After repeat dosing, slight accumulation occurred,
There is only very limited information on repeat dosing intervals less than 6 months see section 5.1.
Repeat dosing of 0.5 to 2 g results in 15%- 36% accumulation above single dose values.
In addition, hyperpigmentation in the skin and eyes and corneal opacity in dogs and cataracts in rats were observed following repeat dosing.
On repeat dosing, maximum plasma concentrations of idebenone are reached on average within 1 hour median 0.67 h range: 0.33-2.00 h.
increase salmeterol accumulation with repeat dosing.
Repeat dosing in yearly intervals showed that there was no difference in safety profile after first,
this is shortened to approximately 20 minutes following repeat dosing.
Following repeat dosing of inhaled umeclidinium bromide, steady state was achieved within
In a thorough QT study in healthy subjects, an increase in heart rate(6 to 8 bpm) was observed after repeat dosing with albiglutide 50 mg compared to baseline values.
The effects of repeat dosing of ambrisentan(10 mg)
associated with high parenteral doses of cephalosporins have been shown to be reversible in animals during repeat dosing.
The effects of acute and repeat dosing of rifampicin(600 mg once daily)
nearly 50% of patients received repeat dosing with 4 or more doses. .
The effects of repeat dosing of ketoconazole(400 mg once daily)
this is the terminal half-life that can be expected upon complete saturation of target mediated clearance and repeat dosing of daratumumab.
Following repeat dosing of 125 micrograms doses every two weeks by subcutaneous administration, the volume of distribution uncorrected for bioavailability(mean±SE)
The effects of repeat dosing of cyclosporine A(100- 150 mg twice daily) on the steady-state pharmacokinetics of ambrisentan(5 mg once daily), and the effects of repeat dosing of ambrisentan(5 mg once daily)
After repeated dosing, this anthelmintic.
Repeated dosing does not result in accumulation of the compound or metabolites.
If infusion is not possible, repeated dosing with naloxone may be required.
However, the serum clearance increases with repeated dosing while the neutrophil count increases.
Repeated dose toxicity and local tolerance have been studied for up to 4 weeks.
Terminal half-life increases with increasing dose and with repeated dosing.
No effects on reproductive organs were noted in the repeated dose toxicity studies.